Degrees of freedom 3-period full replicate [RSABE / ABEL]

posted by d_labes  – Berlin, Germany, 2015-07-06 13:10 (3210 d 08:13 ago) – Posting: # 15042
Views: 27,830

Dear Zizou!

Did you check the output from your SAS code against your degrees of freedom tables?

Here an example:
Scott Patterson and Byron Jones
"Bioequivalence and Statistics in Clinical Pharmacology"
Chapman and Hall/CRC Press: Boca Raton, London and New York, 2005

/*EXAMPLE 4.2*/
74 subjects, 3 periods, sequences TRR/RTT, unfortunately unbalanced with 35/39 subjects
PK metric Cmax without missings

Your SAS code according to the EMA crippled model with Proc GLM gives:
                   degrees of freedom
source                type I  type III
subject                73       72
  -sequence             1        0
  -subject(sequence)   72       72
period                  1        1
error                  34       34
total                 108      108

The type III df=0 for sequence or the changing df for subjects effects illustrates the typical mess with the EMA model.

Some differences to yours w.r.t. subject and total :cool:.

Fortunately the df's for the intra-subject variability of the reference don't play a role in the EMA recommended method for scaling of the BE acceptance ranges.

BTW: Your df's are correct for sequence balanced designs, if you use only the data for subjects with replicates of the Reference or if you evaluate via intra-subject contrasts like in the FDA recommended evaluation according to the progesterone guidance.

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
22,988 posts in 4,825 threads, 1,661 registered users;
100 visitors (0 registered, 100 guests [including 6 identified bots]).
Forum time: 21:23 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5